COVID-19 updates, including vaccine information, for our patients and visitors Learn More
Coronavirus-Related News from UC San Diego Health
8/10/2022
A UC San Diego-led program that monitors wastewater for the presence of SARS-CoV-2 and which has effectively predicted subsequent surges in COVID-19 cases in San Diego has been expanded to detect the ...
6/21/2022
COVID-19 rebound following Paxlovid treatment likely due to insufficient drug exposure, UC San Diego researchers find after showing rebound patient did not show drug resistance or impaired immunity.
6/15/2022
A UC San Diego study describes the short- and long-term neurological symptoms of SARS-CoV-2 infection, and identifies a new group of COVID-19 long-haulers with advanced motor and cognitive symptoms.
4/6/2022
UC San Diego has joined a Phase II clinical trial to evaluate various additional COVID-19 booster shots. The trial seeks to understand if different vaccine regimens can broaden immune responses in adu ...
3/21/2022
UC San Diego Health is now administering Evusheld to eligible, immunocompromised patients to protect against the COVID-19 virus.
2/28/2022
New York Times
Features Joel Wertheim, PhD
2/28/2022
The Medical News
Features Rob Knight, PhD
2/28/2022
STAT
Features UC San Diego School of Medicine
2/28/2022
San Diego Union Tribune
Features Howard Taras, MD
2/28/2022
Fairfield Daily Republic
Features Shira Abeles, MD
2/28/2022
KPBS
Features Lucy Horton, MD, MPH
2/24/2022
10News
Features Lucy Horton, MD, MPH
2/23/2022
San Diego Union Tribune
Features Jess Mandel, MD
12/10/2021
Few places in the country are better equipped to detect new virus variants than San Diego, where researchers at UC San Diego School of Medicine and Scripps Research, working with county public health ...
11/12/2021
A novel study — led by University of California San Diego and UCLA, in collaboration with the La Jolla Institute for Immunology — is assessing whether medicinal mushrooms and Chinese herbs provide the ...
10/26/2021
Researchers at University of California San Diego School of Medicine tested the same treatment for kids with Kawasaki disease and rare COVID-19 reaction.